Skip to content
PeptideAgent

Telehealth providers in Vermont

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in Vermont, including asynchronous care. What Vermont requires of telehealth prescribers and pharmacies, plus verified listings.

Vermont at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving Vermont

No verified telehealth providers serving Vermont are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in Vermont

18 V.S.A. section 9361 lets a Vermont-licensed health care provider prescribe, dispense, or administer drugs after an appropriate examination performed in person, through telemedicine, or by instrumentation and diagnostic equipment that transmits images and medical records electronically, and it holds electronic prescribing to the same standards as a traditional setting. The section also covers services delivered by store-and-forward means, requires the originating site to obtain informed consent for store-and-forward services, and preserves the patient's right to a later real-time or in-person visit. Definitions follow 8 V.S.A. section 4098a (telemedicine and store-and-forward). The prescriber must be licensed in Vermont or practice under Vermont's telehealth licensure or registration pathway administered by the Office of Professional Regulation. Because the statute expressly recognizes examination through transmitted images and records and store-and-forward delivery, this record marks asynchronous prescribing as allowed, subject to the standard of care. GLP-1 medicines and the peptides in this database are not controlled substances. [4] [5] [6]

Compounded GLP-1 access in Vermont

A pharmacy compounding a GLP-1 for a Vermont patient must hold the appropriate Vermont drug outlet license, including a nonresident license if it ships from out of state. [1] [8] [10]

Research use only sellers in Vermont

Under 26 V.S.A. chapter 36, drugs may be dispensed to Vermont patients only by licensed pharmacists working in licensed drug outlets, so a seller shipping "research use only" injectable peptides to Vermont consumers is not a licensed outlet. [7] [11]

How to check a telehealth provider in Vermont

  1. Confirm the prescriber is licensed or registered to treat patients located in Vermont; the telehealth rules above explain what Vermont requires. [4] [5] [6]
  2. Ask which pharmacy will fill the prescription and check it in the Vermont Board of Pharmacy (Office of Professional Regulation, Vermont Secretary of State) license lookup. [1] [2] [3] [7] [8] [9]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Vermont. [7] [11]

Common questions in Vermont

Does Vermont allow store-and-forward telehealth?

Yes. Section 9361 covers services delivered by store-and-forward means, requires informed consent at the originating site, and keeps the patient's right to a later real-time or in-person visit. Definitions come from 8 V.S.A. section 4098a. [5] [6]

All peptide legal questions for Vermont

Sources

  1. [1]Vermont Board of Pharmacy (Office of Professional Regulation)
  2. [2]Vermont Board of Pharmacy: statutes, rules, and resources
  3. [3]Administrative Rules for the Vermont Board of Pharmacy, effective February 1, 2026 (rules 6-2, 7-4, 10-4, 10-9)
  4. [4]Vermont Office of Professional Regulation
  5. [5]18 V.S.A. section 9361, Health care providers delivering health care services through telemedicine or by store-and-forward means
  6. [6]8 V.S.A. section 4098a, Coverage of health care services delivered through telemedicine and by store-and-forward means (definitions)
  7. [7]26 V.S.A. chapter 36, Pharmacy
  8. [8]26 V.S.A. section 2061, Registration and licensure of drug outlets
  9. [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  10. [10]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  11. [11]21 U.S.C. 331, Prohibited acts